Breast Cancer Care

Latest articles

Kadcyla’s rejection from NHS access

Emma Pennery, Clinical Director at Breast Cancer Care says: “Kadcyla being rejected from routine NHS access will come as another devastating blow to women with HER-2 positive advanced breast cancer, denying them the chance of a longer and much better quality of life”.